These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14709872)

  • 21. Benzothiophene and naphthalene derived constrained SERMs.
    Wallace OB; Bryant HU; Shetler PK; Adrian MD; Geiser AG
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5103-6. PubMed ID: 15380208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor binding characteristics of 1,11 beta-ethanoestradiol: effect of a 1,11 beta-bridge on steroidal estrogen.
    Napolitano E; Fiaschi R; Hanson RN
    J Steroid Biochem Mol Biol; 1990 Oct; 37(2):295-300. PubMed ID: 2268562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.
    Blizzard TA; DiNinno F; Chen HY; Kim S; Wu JY; Chan W; Birzin ET; Yang YT; Pai LY; Hayes EC; DaSilva CA; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3912-6. PubMed ID: 15993065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-affinity of a series of 7 alpha-undecylestradiol derivatives: a potential vector for therapy and imaging of estrogen-receptor-positive cancers.
    DaSilva JN; van Lier JE
    J Med Chem; 1990 Jan; 33(1):430-4. PubMed ID: 2296033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel nonsteroidal selective estrogen receptor modulators. Carbon and heteroatom replacement of oxygen in the ethoxypiperidine region of raloxifene.
    Schmid CR; Sluka JP; Duke KM; Glasebrook AW
    Bioorg Med Chem Lett; 1999 Feb; 9(4):523-8. PubMed ID: 10098655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain.
    Kim YW; Mobley JA; Brueggemeier RW
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1475-8. PubMed ID: 12668015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator.
    Zhang JX; Labaree DC; Mor G; Hochberg RB
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3527-35. PubMed ID: 15240642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
    Yang C; Xu G; Li J; Wu X; Liu B; Yan X; Wang M; Xie Y
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1505-7. PubMed ID: 15713417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
    Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
    J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies.
    Dickerson R; Keller LH; Safe S
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):287-98. PubMed ID: 8545839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates.
    Ahmed N; Dubuc C; Rousseau J; Bénard F; van Lier JE
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3212-6. PubMed ID: 17379515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological activities of a novel selective oestrogen receptor modulator derived from raloxifene (Y134).
    Ning M; Zhou C; Weng J; Zhang S; Chen D; Yang C; Wang H; Ren J; Zhou L; Jin C; Wang MW
    Br J Pharmacol; 2007 Jan; 150(1):19-28. PubMed ID: 17115070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens.
    Hartmann RW
    J Med Chem; 1986 Sep; 29(9):1668-74. PubMed ID: 3018243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomedicine. Defining the "S" in SERMs.
    Katzenellenbogen BS; Katzenellenbogen JA
    Science; 2002 Mar; 295(5564):2380-1. PubMed ID: 11923515
    [No Abstract]   [Full Text] [Related]  

  • 36. Protein structure-based design, synthesis strategy and in vitro pharmacological characterization of estrogen receptor alpha and beta selective compounds.
    Hillisch A; Peters O; Kosemund D; Müller G; Walter A; Elger W; Fritzemeier KH
    Ernst Schering Res Found Workshop; 2004; (46):47-62. PubMed ID: 15248504
    [No Abstract]   [Full Text] [Related]  

  • 37. Design, synthesis and bioevaluation of novel candidate selective estrogen receptor modulators.
    Yadav Y; Maclean ED; Bhattacharyya A; Parmar VS; Balzarini J; Barden CJ; Too CK; Jha A
    Eur J Med Chem; 2011 Sep; 46(9):3858-66. PubMed ID: 21680064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based approach for the discovery of novel selective estrogen receptor modulators.
    Rosano C; Stec-Martyna E; Lappano R; Maggiolini M
    Curr Med Chem; 2011; 18(8):1188-94. PubMed ID: 21291367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the cytotoxic agent estramustine phosphate (Estracyt) with the estrogen receptor of the human uterus.
    Muechler EK; Kohler D
    Gynecol Oncol; 1979 Dec; 8(3):330-8. PubMed ID: 510999
    [No Abstract]   [Full Text] [Related]  

  • 40. An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators.
    O'Connor JC; Cook JC; Craven SC; Van Pelt CS; Obourn JD
    Fundam Appl Toxicol; 1996 Oct; 33(2):182-95. PubMed ID: 8921337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.